Product NDC: | 64011-124 |
Proprietary Name: | Clindesse |
Non Proprietary Name: | clindamycin phosphate |
Active Ingredient(s): | 20 mg/g & nbsp; clindamycin phosphate |
Administration Route(s): | VAGINAL |
Dosage Form(s): | CREAM |
Coding System: | National Drug Codes(NDC) |
Product NDC: | 64011-124 |
Labeler Name: | Ther-Rx Corporation |
Product Type: | HUMAN PRESCRIPTION DRUG |
FDA Application Number: | NDA050793 |
Marketing Category: | NDA |
Start Marketing Date: | 20091101 |
Package NDC: | 64011-124-08 |
Package Description: | 5 g in 1 APPLICATOR (64011-124-08) |
NDC Code | 64011-124-08 |
Proprietary Name | Clindesse |
Package Description | 5 g in 1 APPLICATOR (64011-124-08) |
Product NDC | 64011-124 |
Product Type Name | HUMAN PRESCRIPTION DRUG |
Non Proprietary Name | clindamycin phosphate |
Dosage Form Name | CREAM |
Route Name | VAGINAL |
Start Marketing Date | 20091101 |
Marketing Category Name | NDA |
Labeler Name | Ther-Rx Corporation |
Substance Name | CLINDAMYCIN PHOSPHATE |
Strength Number | 20 |
Strength Unit | mg/g |
Pharmaceutical Classes | Decreased Sebaceous Gland Activity [PE],Lincosamide Antibacterial [EPC],Lincosamides [Chemical/Ingredient] |